Sector Chart Kinarus Therapeutics Holding AG

Equities

Delayed Swiss Exchange Other stock markets 10:01:56 18/07/2024 BST			5-day change	1st Jan Change
5.96 ^CHF	-0.67%		-7.69%	+232.59%

04-26	Kinarus Therapeutics Completes Merger with Unit, Rebrands as Curatis	MT
04-25	Curatis AG completed the acquisition of Kinarus Therapeutics Holding AG for CHF 18.3 million in a reverse merger transaction.	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

	Capi.	Sales growth	Profitability	Finances	EV / Sales	P/E ratio